American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: Tamoxifen and raloxifene Review uri icon

Overview

MeSH Major

  • Anticarcinogenic Agents
  • Breast Neoplasms
  • Estrogen Antagonists
  • Raloxifene Hydrochloride
  • Tamoxifen

abstract

  • American Society of Clinical Oncology.

publication date

  • June 1999

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 10561236

Additional Document Info

start page

  • 1939

end page

  • 55

volume

  • 17

number

  • 6